Stories Tagged: pharmaceuticals

🤷🤷🤷
Investment Opportunities in Drug Stocks: Talaria Capital Tips Roche for 35% Jump

In the ever-evolving financial markets, investment opportunities arise in various sectors.... (2 revisions)

🤷🤷🤷
EU Investigates AliExpress for Selling Counterfeit Drugs, Police Step Up Efforts to Stop Illegal Sale of Pills

Pharmaceutical manufacturer Eli Lilly has filed a complaint with the US International Trade... (3 revisions)

🤷🤷🤷
Miami-Dade Mayor Visits Japan to Enhance Investment and Trade for South Florida

Miami-Dade Mayor Daniella Levine Cava is currently on a visit to Japan to promote investment and... (3 revisions)

🤷🤷🤷
ANI Pharmaceuticals and Enanta Pharmaceuticals: A Tale of Two Pharmaceutical Companies

ANI Pharmaceuticals Inc. is a shining example of innovation and success in the pharmaceutical... (4 revisions)

🤷🤷🤷
Port of Cork Enhances Trade Links with Indiana through New MoU

The Port of Cork Company (PoCC) has taken a significant step in strengthening its trade ties... (5 revisions)

🤷🤷🤷
AAR Healthcare Expands with New Outpatient Centre in Kamakis, Kenya

FarmaKeio Custom Compounding, a pharmaceutical company based in Richardson, Texas, has acquired... (6 revisions)

🤷🤷🤷
Boosting U.S.-Brazil Health and Trade Cooperation

In a pivotal moment for U.S.-Brazil relations, strengthening the Brazilian Health Regulatory... (8 revisions)

🤷🤷🤷
Ozempic: A Game Changer in Addiction and Chronic Disease Treatment?

Ozempic, a diabetes treatment known for its ability to manage blood sugar levels and promote... (9 revisions)

🤷🤷🤷
Hong Kong's New Drug-Approval Agency: A Step Towards Healthcare Innovation

In a significant move to enhance healthcare innovation, Hong Kong plans to establish the Hong... (9 revisions)

🤷🤷🤷
Ateco Pharma Egypt Seeks Collaboration with US Embassy for Export Growth

Ateco Pharma Egypt hosted a delegation from the US Embassy on December 14, 2024, to explore... (9 revisions)

🤷🤷🤷
Daré Bioscience Reports Q4 2023 Earnings and Updates on Women's Health Product Development

Daré Bioscience, Inc. (NASDAQ:DARE) reported its Q4 2023 earnings, surpassing expectations with... (11 revisions)

🤷🤷🤷
Investment Firms Adjust Holdings in Oaktree Specialty Lending, The Oncology Institute, A. O. Smith Co., Omnicom Group Inc., and GSK plc

Greenwich Investment Management Inc., a financial management company, has reduced its holdings... (11 revisions)

🤷🤷🤷
GSK to Pay £1.7bn to Settle Tens of Thousands of Zantac Lawsuits

GlaxoSmithKline (GSK) has reached a significant settlement agreement to pay up to $2.2 billion... (16 revisions)

🤷🤷🤷
Sanofi's Opella Sale: Balancing Investment and National Concerns

The planned sale of Doliprane, France's best-selling painkiller, to US investors has ignited a... (20 revisions)

🤷🤷🤷
FDA Approves Journavx: A Non-Addictive Painkiller

On January 30, 2025, the FDA approved Vertex Pharmaceuticals' Journavx (suzetrigine) for... (22 revisions)

🤷🤷🤷
Britain Chooses Pfizer Over GSK for RSV Vaccine

Antibiotic-resistant infections continue to pose a significant threat, but recent breakthroughs... (22 revisions)

🤷🤷🤷
Mixed Reactions to President Biden's State of the Union Address and Fashion Choices

President Joe Biden delivered his final State of the Union address on March 7, 2024. The address... (25 revisions)

🤷🤷🤷
Switzerland's Balancing Act: Navigating Trade Between China and the US

Switzerland finds itself in a precarious position as it navigates the complex geopolitical... (28 revisions)

🤷🤷🤷
Sage Therapeutics Shares Surge on Biogen's Acquisition Proposal

Sage Therapeutics Inc. (NASDAQ:SAGE) saw its shares soar over 45% to $8.09 following a... (29 revisions)

🤷🤷🤷
What Lies Ahead for North Carolina's Manufacturing Sector?

Manufacturing in North Carolina has a rich historical significance, previously dominated by... (30 revisions)

🤷🤷🤷
Mark Cuban Critiques Pharmaceutical Industry at Davos

During a recent event at Davos, billionaire entrepreneur Mark Cuban sharply criticized the... (91 revisions)